Interplay of opposing fate choices stalls oncogenic growth in murine skin epithelium.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33393458.
- Also identified by DOI 10.7554/eLife.54618 and PMC identifier 7817173.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Skin epithelium can accumulate a high burden of oncogenic mutations without morphological or functional consequences. To investigate the mechanism of oncogenic tolerance, we induced Hras<sup>G12V</sup> in single murine epidermal cells and followed them long term. We observed that Hras<sup>G12V</sup> promotes an early and transient clonal expansion driven by increased progenitor renewal that is replaced with an increase in progenitor differentiation leading to reduced growth. We attribute this dynamic effect to emergence of two populations within oncogenic clones: renewing progenitors along the edge and differentiating ones within the central core. As clone expansion is accompanied by progressive enlargement of the core and diminishment of the edge compartment, the intraclonal competition between the two populations results in stabilized oncogenic growth. To identify the molecular mechanism of Hras<sup>G12V</sup>-driven differentiation, we screened known Ras-effector in vivo and identified Rassf5 as a novel regulator of progenitor fate choice that is necessary and sufficient for oncogene-specific differentiation.
Medical subject headings
- Adaptor Proteins, Signal Transducing
- Apoptosis Regulatory Proteins
- Carcinogenesis
- Epidermal Cells
- Epithelial Cells